{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "11256132",
  "DateCompleted": {
    "Year": "2001",
    "Month": "04",
    "Day": "12"
  },
  "DateRevised": {
    "Year": "2017",
    "Month": "11",
    "Day": "16"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "fre"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0370-629X",
      "JournalIssue": {
        "Volume": "56",
        "Issue": "1",
        "PubDate": {
          "Year": "2001",
          "Month": "Jan"
        }
      },
      "Title": "Revue medicale de Liege",
      "ISOAbbreviation": "Rev Med Liege"
    },
    "ArticleTitle": "[Is it reasonable to prescribe growth hormones in the elderly?].",
    "Pagination": {
      "StartPage": "17",
      "EndPage": "24",
      "MedlinePgn": "17-24"
    },
    "Abstract": {
      "AbstractText": [
        "During normal aging, there is a +/- 60% decrease of the endogenous GH secretion (\"somatopause\"). However it is safe to prescribe GH therapy only to those people who show a clear cut decrease of GH release as evidenced by low integrated 24 hr secretion and/or low plasma IGF-1. In our view, a complete clinical check up must also show, on the one hand, an abnormal decrease of the optimal quality of life and, on the other hand a willing to maintain a reasonable intellectual and physical activity in the absence of major clinical and biological abnormalities. The benefits are likely to be an increase of muscular strength and of exercise tolerance, a decrease of trabecular osteopenia, a decrease of abdominal obesity, an increase of immunocompetence and a general improvement of the \"quality of life\". A \"pharmacological\" prescription is contra-indicated whereas very low dose regimen could induce, through feed back mechanism, a putative decrease of endogenous GH-RH (and GHRPs?) function whose deleterious psychoneuroendocrine effects remain to be demonstrated."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Service Universitaire d'Endocrinologie, Unit\u00e9 de Psychoneuroendocrinologie, CHU et CHR Citadelle."
          }
        ],
        "LastName": "Legros",
        "ForeName": "J J",
        "Initials": "JJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Geenen",
        "ForeName": "V",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Delmotte",
        "ForeName": "P",
        "Initials": "P"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ],
    "VernacularTitle": "Est-il raisonnable de prescrire de l'hormone de croissance aux personnes \u00e2g\u00e9es?"
  },
  "MedlineJournalInfo": {
    "Country": "Belgium",
    "MedlineTA": "Rev Med Liege",
    "NlmUniqueID": "0404317",
    "ISSNLinking": "0370-629X"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "12629-01-5",
      "NameOfSubstance": "Human Growth Hormone"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Activities of Daily Living"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [
        "drug effects",
        "physiology",
        "psychology"
      ],
      "DescriptorName": "Aging"
    },
    {
      "QualifierName": [
        "etiology",
        "prevention & control"
      ],
      "DescriptorName": "Bone Diseases, Metabolic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Contraindications"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Prescriptions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Exercise Tolerance"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Geriatric Assessment"
    },
    {
      "QualifierName": [
        "deficiency",
        "physiology",
        "therapeutic use"
      ],
      "DescriptorName": "Human Growth Hormone"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug effects",
        "physiology"
      ],
      "DescriptorName": "Immune Tolerance"
    },
    {
      "QualifierName": [
        "etiology",
        "prevention & control"
      ],
      "DescriptorName": "Obesity"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Patient Selection"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Quality of Life"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Safety"
    }
  ],
  "NumberOfReferences": "41"
}